Jérémie Richard - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Jérémie Richard's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Jérémie Richard

Jérémie Richard

Verified

Stringer, Agence France-Presse (AFP)

England

Final Covers

Industrial Engineering , Pumps , Pumping Systems , Motors , Motor Driven Systems

Doesn’t Cover

Science, Technology

Journalist Type

Seniority Positions

Content

Total articles 1568

  • Expanded access to psychedelic treatments: comparing American and Canadian policies

    By Jérémie Richard, Albert Garcia-Romeu, Jack E Henningfield| The BMJ Verified The United States Food and Drug Administration’s (FDA’s) August 2024 determination that an additional phase III study will be required to consider the approval of midomafetamine for the treatment of post-traumatic stress disorder (PTSD) could delay the potential approval of this promising treatment by several years.1 In principle, the FDA’s expanded access pathway could enable broader access to investigational treatments as clinical trials continue.

    By Jérémie Richard, Albert Garcia-Romeu, Jack E Henningfield · The BMJ

    Feb. 19, 2025

  • Eruption volcanique en Islande, la septième en un an

    By Jérémie Richard| L'union Verified Diffusées en direct, des images montrent de la lave rouge orangée jaillissant d'une longue fissure entourée d'une épaisse fumée. "La longueur de la fissure est estimée à 2,5 km et son extrémité sud se trouve à Sýlingarfell. Compte tenu de la situation actuelle, cette éruption est plus petite que la précédente" qui a eu lieu fin août, a indiqué l'IMO dans un communiqué.

    By Jérémie Richard · L'union

    Nov. 20, 2024

  • Expanded access to psychedelic treatments: comparing American and Canadian policies

    By Jérémie Richard, Albert Garcia-Romeu, Jack E Henningfield| The BMJ Verified The United States Food and Drug Administration’s (FDA’s) August 2024 determination that an additional phase III study will be required to consider the approval of midomafetamine for the treatment of post-traumatic stress disorder (PTSD) could delay the potential approval of this promising treatment by several years.1 In principle, the FDA’s expanded access pathway could enable broader access to investigational treatments as clinical trials continue.

    By Jérémie Richard, Albert Garcia-Romeu, Jack E Henningfield · The BMJ

    Feb. 19, 2025

As seen in

Company Info

Agence France-Presse (AFP)

Agence France-Presse (AFP) is a prominent global news agency known for its extensive and reliable coverage of international events. With a network of 1,700 journalists, AFP provides in-depth reporting on various topics, including business, politics, health, and culture. It has the largest news gathering footprint worldwide, ensuring comprehensive coverage of significant issues affecting daily life. AFP offers a variety of services designed for large companies, startups, agencies, international institutions, and NGOs. These include corporate content services that deliver trusted editorial content, a digital verification network for fact-checking, and tailored news feeds that provide customized news dispatches in six languages, available 24/7. Additionally, AFP produces over 3,000 news dispatches daily and offers photo services to capture significant events.

'+33 1 40 41 46 46

Founded: 1835

Jérémie Richard - Profile and Journalist Details